Managerial change within the Board of PHOENIX Pharma Italia

In November 2022, Admenta Italia and Gruppo Comifar joined forces to develop Italy’s first fully-integrated and most customer-centric healthcare provider under the roof of PHOENIX Pharma Italia. The company is committed to invest long-term into its wholesale and retail portfolio to increase the accessibility to and quality of healthcare services in Italy.

As first milestones, the company is innovating its pharmaceutical retail concept und the new BENU brand and is leveraging its market-leading retail expertise to strengthen its Valore Salute network.

The transaction and integration process over the recent months has been strongly facilitated by Mr. Domenico Laporta, in his capacity as Co-CEO of PHOENIX Pharma Italia and Managing Director of both Admenta Italia and Gruppo Comifar. Today, we would like to inform you, that Mr. Laporta is leaving the company effective as of 3 October 2023 on mutual agreement and will continue his professional career outside of PHOENIX group. Until 31. December 2023, he will support a smooth hand-over of activities and provide his expert knowledge to the company.

We would like to take this opportunity to thank Mr. Laporta for his extraordinary leadership, outstanding commitment, and exceptional contributions to the company’s success over the course of the last 18 years. In ever increasing prominent roles, especially during his extensive time as Managing Director, he has been a driving force in the company’s developments of Italy’s most customer-centric and award-winning pharmaceutical retail chain.

The future Management Board will consist of:

  • Joachim Sowada as the CEO of PHOENIX Pharma Italia and Managing Director of both Gruppo COMIFAR and ADMENTA Italia
  • Claudia Ciuffani as Group CFO
  • Arianna Furia as Group Director Customers & Channels Retail
  • Lorenzo Clerici as Group Director Customers & Channels Wholesale
  • Vincenzo Masci as the Group Director Commercial & Marketing
  • Raffaele Testa as the Group Director Operations & Logistics

The PHOENIX Pharma Italia Management Board is fully committed to its growth plan and determined to strengthen the quality of healthcare services for pharmacy customers and retail consumers.

We wish Mr. Domenico Laporta all the best in his future professional tenure.